EUVIMEDEUVIMED entdecken
Open Access

Correction of age-associated defects in dendritic cells enables CD4+ T cells to eradicate tumors

Dania Zhivaki, Stephanie N Kennedy, Josh Park, Francesco Boriello, Pascal Devant, Anh Cao, Kristin M Bahleda, Shane Murphy, Cristin McCabe, Charles L Evavold, Kate L Chapman, Ivan Zanoni und 3 weitere

Cell · 2024-07 · 187 (15) · 3888-3903.e18

DOI: 10.1016/j.cell.2024.05.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2024-07. Verfasst von Dania Zhivaki und 14 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School and Division of Gastroenterology, Boston Children's Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Dendritic Cells, CD4-Positive T-Lymphocytes, Mice, Inbred C57BL. Die Arbeit wurde bisher 101-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIAID NIH HHS, NIDDK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Defective host defenses later in life are associated with changes in immune cell activities, suggesting that age-specific considerations are needed in immunotherapy approaches. In this study, we found that PD-1 and CTLA4-based cancer immunotherapies are unable to eradicate tumors in elderly mice. This defect in anti-tumor activity correlated with two known age-associated immune defects: diminished abundance of systemic naive CD8+ T cells and weak migratory activities of dendritic cells (DCs). We identified a vaccine adjuvant, referred to as a DC hyperactivator, which corrects DC migratory defects in the elderly. Vaccines containing tumor antigens and DC hyperactivators induced T helper type 1 (TH1) CD4+ T cells with cytolytic activity that drive anti-tumor immunity in elderly mice. When administered early in life, DC hyperactivators were the only adjuvant identified that elicited anti-tumor CD4+ T cells that persisted into old age. These results raise the possibility of correcting age-associated immune defects through DC manipulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsCD4-Positive T-LymphocytesMice, Inbred C57BLAnimalsMiceAgingCD8-Positive T-LymphocytesImmunotherapyCancer VaccinesFemaleNeoplasmsProgrammed Cell Death 1 ReceptorCTLA-4 AntigenCell MovementAntigens, Neoplasm

Stichwörter der Autor:innen

PGPCT cellscancercheckpoint inhibitor therapydendritic cellselderlyhyperactivationimmunotherapyinnate immunitytumor immunityvaccine

Substanzen

Cancer VaccinesProgrammed Cell Death 1 ReceptorCTLA-4 AntigenAntigens, Neoplasm

Autor:innen und Institutionen

  • Harvard Medical School and Division of Gastroenterology, Boston Children's Hospital, Boston, MA, USA.
  • Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Harvard Medical School and Division of Immunology, Boston Children's Hospital, Boston, MA, USA.
  • Harvard Medical School and Division of Gastroenterology, Boston Children's Hospital, Boston, MA, USA. Electronic address: jonathan.kagan@childrens.harvard.edu.

Förderung

  • NIDDK NIH HHS
  • NIAID NIH HHS
  • NIDDK
  • National Institutes of Health
  • National Security Agency
  • NIAID
  • eNeura Therapeutics

Zitieren

APA

Zhivaki, D., Kennedy, S. N., Park, J., Boriello, F., Devant, P., Cao, A., Bahleda, K. M., Murphy, S., McCabe, C., Evavold, C. L., Chapman, K. L., Zanoni, I., Ashenberg, O., Xavier, R. J., & Kagan, J. C. (2024). Correction of age-associated defects in dendritic cells enables CD4+ T cells to eradicate tumors. Cell, 187(15), 3888-3903.e18. https://doi.org/10.1016/j.cell.2024.05.026

Vancouver

Zhivaki D, Kennedy SN, Park J, Boriello F, Devant P, Cao A, et al. Correction of age-associated defects in dendritic cells enables CD4+ T cells to eradicate tumors. Cell. 2024;187(15):3888-3903.e18. doi:10.1016/j.cell.2024.05.026

BibTeX
@article{Zhivaki2024,
  author = {Zhivaki, Dania and Kennedy, Stephanie N and Park, Josh and Boriello, Francesco and Devant, Pascal and Cao, Anh and Bahleda, Kristin M and Murphy, Shane and McCabe, Cristin and Evavold, Charles L and Chapman, Kate L and Zanoni, Ivan and Ashenberg, Orr and Xavier, Ramnik J and Kagan, Jonathan C},
  title = {Correction of age-associated defects in dendritic cells enables CD4+ T cells to eradicate tumors},
  journal = {Cell},
  year = {2024},
  volume = {187},
  number = {15},
  pages = {3888--3903.e18},
  doi = {10.1016/j.cell.2024.05.026}
}
Kostenlos starten →